Literature DB >> 26962410

Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation.

Vemana Gowd1, Abhignan Gurukar1, Nandini D Chilkunda1.   

Abstract

Glycosaminoglycans (GAGs) play a significant role in various aspects of cell physiology. These are complex polymeric molecules characterized by disaccharides comprising of uronic acid and amino sugar. Compounded to the heterogeneity, these are variously sulfated and epimerized depending on the class of GAG. Among the various classes of GAG, namely, chondroitin/dermatan sulfate, heparin/heparan sulfate, keratan sulfate and hyaluronic acid (HA), only HA is non-sulfated. GAGs are known to undergo remodeling in various tissues during various pathophysiological conditions, diabetes mellitus being one among them. These changes will likely affect their structure thereby impinging on their functionality. Till date, diabetes has been shown to affect GAGs in organs such as kidney, liver, aorta, skin, erythrocytes, etc. to name a few, with deleterious consequences. One of the mainstays in the treatment of diabetes is though dietary means. Various dietary factors are known to play a significant role in regulating glucose homeostasis. Furthermore, in recent years, there has been a keen interest to decipher the role of dietary factors on GAG metabolism. This review focuses on the remodeling of GAGs in various organs during diabetes and their modulation by dietary factors. While effect of diabetes on GAG metabolism has been worked out quite a bit, studies on the role of dietary factors in their modulation has been few and far between. We have tried our best to give the latest reports available on this subject.

Entities:  

Keywords:  Diabetes; Dietary factors; Glycosaminoglycans; Proteoglycans; Remodeling

Year:  2016        PMID: 26962410      PMCID: PMC4766247          DOI: 10.4239/wjd.v7.i4.67

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  76 in total

Review 1.  The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

Authors:  P King; I Peacock; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 2.  The molecular diversity of glycosaminoglycans shapes animal development.

Authors:  Hannes E Bülow; Oliver Hobert
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 3.  Advanced glycation end products and diabetic nephropathy.

Authors:  Merlin C Thomas; Josephine M Forbes; Mark E Cooper
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

4.  Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1.

Authors:  Anna M Vogt; Antonio Barragan; Qijun Chen; Fred Kironde; Dorothe Spillmann; Mats Wahlgren
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 5.  Keratan sulfate: structure, biosynthesis, and function.

Authors:  J L Funderburgh
Journal:  Glycobiology       Date:  2000-10       Impact factor: 4.313

6.  Primers of glycosaminoglycan biosynthesis from Peruvian rain forest plants.

Authors:  W H Taylor; A Sinha; I A Khan; S T McDaniel; J D Esko
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

7.  Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor.

Authors:  Anna M Vogt; Gerhard Winter; Mats Wahlgren; Dorothe Spillmann
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

8.  Presence of glycosaminoglycans in retinal capillary basement membrane.

Authors:  M P Cohen; C J Ciborowski
Journal:  Biochim Biophys Acta       Date:  1981-05-18

9.  Quantitative determination of glycosaminoglycans in tears of diabetic patients.

Authors:  Marilita M Moschos; Alexandros A Rouvas; Spyridon Papadimitriou; Athanasios Kotsolis; Nikolaos Sitaras; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-09

10.  Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys.

Authors:  Iris J Edwards; Janice D Wagner; Catherine A Vogl-Willis; Kenneth N Litwak; William T Cefalu
Journal:  Cardiovasc Diabetol       Date:  2004-04-29       Impact factor: 9.951

View more
  14 in total

1.  One-pot analysis of sulfated glycosaminoglycans.

Authors:  C B Shrikanth; J Sanjana; Nandini D Chilkunda
Journal:  Glycoconj J       Date:  2017-12-05       Impact factor: 2.916

Review 2.  Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.

Authors:  Solomon A Agere; Eugene Y Kim; Nahid Akhtar; Salahuddin Ahmed
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

3.  Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.

Authors:  Akhilesh Kaushal; Hongmei Zhang; Wilfried J J Karmaus; Todd M Everson; Carmen J Marsit; Margaret R Karagas; Shih-Fen Tsai; Hui-Ju Wen; Shu-Li Wang
Journal:  Environ Health       Date:  2017-05-30       Impact factor: 5.984

4.  Blueberry metabolites restore cell surface glycosaminoglycans and attenuate endothelial inflammation in diabetic human aortic endothelial cells.

Authors:  Brett Ronald Cutler; Samira Gholami; Jie Shi Chua; Balagurunathan Kuberan; Pon Velayutham Anandh Babu
Journal:  Int J Cardiol       Date:  2018-03-08       Impact factor: 4.164

5.  Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype.

Authors:  Florian Job; Shuji Mizumoto; Laurie Smith; Natario Couser; Ashley Brazil; Howard Saal; Melanie Patterson; Margaret I Gibson; Sarah Soden; Neil Miller; Isabelle Thiffault; Carol Saunders; Shuhei Yamada; Katrin Hoffmann; Kazuyuki Sugahara; Emily Farrow
Journal:  BMC Med Genet       Date:  2016-11-21       Impact factor: 2.103

6.  The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.

Authors:  Kiyoe Kurahashi; Seika Inoue; Sumiko Yoshida; Yasumasa Ikeda; Kana Morimoto; Ryoko Uemoto; Kazue Ishikawa; Takeshi Kondo; Tomoyuki Yuasa; Itsuro Endo; Masato Miyake; Seiichi Oyadomari; Toshio Matsumoto; Masahiro Abe; Hiroshi Sakaue; Ken-Ichi Aihara
Journal:  J Atheroscler Thromb       Date:  2017-05-15       Impact factor: 4.928

Review 7.  Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation.

Authors:  Ariane R Pessentheiner; G Michelle Ducasa; Philip L S M Gordts
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

8.  Gene expression patterns in synchronized islet populations.

Authors:  Nikita Mukhitov; Joel E Adablah; Michael G Roper
Journal:  Islets       Date:  2019-05-03       Impact factor: 2.694

9.  Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptor.

Authors:  Canjun Zhu; Zhiyue Xu; Yexian Yuan; Tao Wang; Chang Xu; Cong Yin; Peipei Xie; Pingwen Xu; Hui Ye; Nirali Patel; Sarah Schaul; Lina Wang; Xiaotong Zhu; Songbo Wang; Ping Gao; Qianyun Xi; Yongliang Zhang; Gang Shu; Qingyan Jiang
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-05

Review 10.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.